Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease

por Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Noguchi, Hirohito, Suzuki, Mitsuyuki, Hirosawa, Hiroshi, Imai, Michitaka, Mitobe, Yuta, Yoshida, Toshiaki
Publicado 2021

Relationship Between Sarcopenia and Both Physical Activity and Lifestyle in Patients With Chronic Liver Disease

por Ohashi, Kazuki, Ishikawa, Toru, Hoshi, Asami, Suzuki, Mitsuyuki, Mitobe, Yuta, Yamada, Etsuko, Abeywickrama, Hansani Madushika, Seki, Nao, Koyama, Chikayo, Aoki, Hagiko, Koyama, Yu
Publicado 2018

Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease

por Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Suzuki, Mitsuyuki, Mitobe, Yuta, Yamada, Etsuko, Abeywickrama, Hansani Madushika, Kikuchi, Yuko, Noguchi, Hirohito, Hirosawa, Hiroshi, Koyama, Yu
Publicado 2019

Effect of levocarnitine administration in patients with chronic liver disease

por Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Suzuki, Mitsuyuki, Noguchi, Hirohito, Hirosawa, Hiroshi, Koyama, Fujiko, Kobayashi, Miki, Hirosawa, Shiori, Sugiyama, Kaede, Mitobe, Yuta, Yoshida, Toshiaki
Publicado 2020